Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.

Arcadipane F, Franco P, De Colle C, Rondi N, Di Muzio J, Pelle E, Martini S, Ala A, Airoldi M, Donadio M, De Sanctis C, Castellano I, Ragona R, Ricardi U.

Med Oncol. 2016 Oct;33(10):108. doi: 10.1007/s12032-016-0821-1.

PMID:
27573380
2.

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up.

Bustreo S, Osella-Abate S, Cassoni P, Donadio M, Airoldi M, Pedani F, Papotti M, Sapino A, Castellano I.

Breast Cancer Res Treat. 2016 Jun;157(2):363-71. doi: 10.1007/s10549-016-3817-9.

3.

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life.

Garrone O, Montemurro F, Saggia C, La Verde N, Vandone AM, Airoldi M, De Conciliis E, Donadio M, Lucio F, Polimeni MA, Oletti MV, Giacobino A, Merlano MC.

Springerplus. 2016 Jan 21;5:59. doi: 10.1186/s40064-016-1700-0.

4.

Pituitary lesions in breast cancer patients: A report of three cases.

Fortunati N, Felicetti F, Donadio M, Grossi E, Michelon F, Ritorto G, Arvat E, Brignardello E.

Oncol Lett. 2015 Jun;9(6):2762-2766.

5.

Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients.

Occhipinti S, Sponton L, Rolla S, Caorsi C, Novarino A, Donadio M, Bustreo S, Satolli MA, Pecchioni C, Marchini C, Amici A, Cavallo F, Cappello P, Pierobon D, Novelli F, Giovarelli M.

Clin Cancer Res. 2014 Jun 1;20(11):2910-21. doi: 10.1158/1078-0432.CCR-13-2663.

6.

Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer.

Campagnoli C, Berrino F, Venturelli E, Abbà C, Biglia N, Brucato T, Cogliati P, Danese S, Donadio M, Zito G, Pasanisi P.

Clin Breast Cancer. 2013 Dec;13(6):433-8. doi: 10.1016/j.clbc.2013.08.012.

PMID:
24267731
7.

Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer.

Montemurro F, Prat A, Rossi V, Valabrega G, Sperinde J, Peraldo-Neia C, Donadio M, Galván P, Sapino A, Aglietta M, Baselga J, Scaltriti M.

Mol Oncol. 2014 Feb;8(1):20-6. doi: 10.1016/j.molonc.2013.08.013.

8.

A simple and reproducible prognostic index in luminal ER-positive breast cancers.

Castellano I, Chiusa L, Vandone AM, Beatrice S, Goia M, Donadio M, Arisio R, Muscarà F, Durando A, Viale G, Cassoni P, Sapino A.

Ann Oncol. 2013 Sep;24(9):2292-7. doi: 10.1093/annonc/mdt183.

9.

Intracranial video-EEG and surgery for focal atonic seizures.

Donadío M, Ugarnes G, Segalovich M, Arakaki N, Sanchez Gonzalez F, Petre C, Pomata H, D'Giano C.

Epileptic Disord. 2013 Mar;15(1):62-6. doi: 10.1684/epd.2013.0549.

10.

Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.

Campagnoli C, Pasanisi P, Abbà C, Ambroggio S, Biglia N, Brucato T, Colombero R, Danese S, Donadio M, Venturelli E, Zito G, Berrino F.

Clin Breast Cancer. 2012 Jun;12(3):175-82. doi: 10.1016/j.clbc.2012.03.004.

PMID:
22607767
11.

Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM).

Barni S, Venturini M, Molino A, Donadio M, Rizzoli S, Maiello E, Gori S.

Tumori. 2011 Sep-Oct;97(5):559-63. doi: 10.1700/989.10711.

12.

The effects of Reiki therapy on pain and anxiety in patients attending a day oncology and infusion services unit.

Birocco N, Guillame C, Storto S, Ritorto G, Catino C, Gir N, Balestra L, Tealdi G, Orecchia C, Vito GD, Giaretto L, Donadio M, Bertetto O, Schena M, Ciuffreda L.

Am J Hosp Palliat Care. 2012 Jun;29(4):290-4. doi: 10.1177/1049909111420859.

PMID:
21998438
13.

Epilepsy surgery in Argentina: long-term results in a comprehensive epilepsy centre.

Donadío M, D'Giano C, Moussalli M, Barrios L, Ugarnes G, Segalovich M, Pociecha J, Vázquez C, Petre C, Pomata H.

Seizure. 2011 Jul;20(6):442-5. doi: 10.1016/j.seizure.2011.02.002.

14.

Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience.

Vandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, Ciuffreda L, Scoletta M.

Ann Oncol. 2012 Jan;23(1):193-200. doi: 10.1093/annonc/mdr039.

PMID:
21427065
15.

Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.

Arduino PG, Menegatti E, Scoletta M, Battaglio C, Mozzati M, Chiecchio A, Berardi D, Vandone AM, Donadio M, Gandolfo S, Scully C, Broccoletti R.

J Oral Pathol Med. 2011 Jul;40(6):510-5. doi: 10.1111/j.1600-0714.2010.01004.x.

PMID:
21251073
16.

Underuse of anthracyclines in women with HER-2+ advanced breast cancer.

Montemurro F, Rossi V, Nolè F, Redana S, Donadio M, Martinello R, Verri E, Valabrega G, Rocca MC, Jacomuzzi ME, Viale G, Sapino A, Aglietta M.

Oncologist. 2010;15(7):665-72. doi: 10.1634/theoncologist.2010-0016.

17.

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers.

Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G, Coates AS, Viale G, Sapino A.

Breast Cancer Res Treat. 2010 Dec;124(3):607-17. doi: 10.1007/s10549-010-0761-y.

PMID:
20127405
18.

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison.

Redana S, Donadio M, Nolè F, Jacomuzzi ME, Beano A, Martinello R, Sapino A, Viale G, Aglietta M, Montemurro F.

BMC Cancer. 2010 Feb 1;10:28. doi: 10.1186/1471-2407-10-28.

19.

Cytotoxicity evaluation of Activ GP and Resilon sealers in vitro.

Donadio M, Jiang J, He J, Wang YH, Safavi KE, Zhu Q.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jun;107(6):e74-8. doi: 10.1016/j.tripleo.2009.01.041.

PMID:
19464649
20.

Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era.

Montemurro F, Redana S, Viale G, Sanna G, Donadio M, Valabrega G, del Curto B, Bottini A, Botti G, dei Tos AP, Jacomuzzi ME, Di Bonito M, Danese S, Clavarezza M, Kulka J, Di Palma S, Durando A, Sapino A, Aglietta M.

Clin Breast Cancer. 2008 Oct;8(5):436-42. doi: 10.3816/CBC.2008.n.053.

PMID:
18952558
Items per page

Supplemental Content

Loading ...
Support Center